Acquity® UPLC Protein BEH SEC Column 200Å, 1.7 µm, 4.6 x 300 mm and BEH200 SEC Protein Standard Mix

The ACQUITY UPLC Protein BEH SEC 200 Å column 150x4.6mm, 1.7µm, is a diol-modified BEH-SEC phase for the analysis of proteins and protein aggregates. With a pore size of 200 Å, this modification typically covers a molecular weight range of approximately 10,000 to 450,000 Dalton and is therefore frequently used for monoclonal antibodies, IgG monomers, dimers and smaller aggregates. The ACQUITY UPLC Protein BEH SEC 200 Å combines the efficiency of a UPLC-compatible SEC column with a surface tuned for low adsorption and reproducible protein separations.

Features and Benefits

• UHPLC particles
• BEH, CSH, and HSS particle technologies for broad selectivity
• High reproducibility
• Wide range of phases for method development and routine analysis
• Suitable for pharmaceutical, biopharmaceutical, environmental, food, and research applications

Additional Information

The Waters ACQUITY series includes sub-2-µm UPLC phases based on hybrid particles, high-strength silica, and charged-surface hybrid materials. BEH particles consist of an organic-inorganic hybrid matrix and offer high chemical and mechanical stability. HSS particles provide silica-like selectivity with high pressure stability, while CSH particles enable particularly good peak shapes for basic analytes in LC-MS-friendly mobile phases thanks to a controlled surface charge. Compatible VanGuard or Guard systems protect the main column from matrix components.

Legal Notices

ACQUITY is a registered trademark of Waters Corporation, Milford, Massachusetts, USA.